“Bevacizumab Beyond Progression: Pros”. European Journal of Oncology and Environmental Health 19, no. 1S (March 1, 2014): 33–35. Accessed July 18, 2024. https://mattioli1885journals.com/index.php/EJOEH/article/view/4260.